Sep 13 – 15, 2026
University of Muenster (Castle)
Europe/Berlin timezone

A Vector-Based Influenza Vaccine Reveals the HA Stalk as a Dual Humoral and Cellular Immune Target

Sep 13, 2026, 6:01 PM
1m
Aula (1st floor)

Aula (1st floor)

Poster presentation Antivirals and Vaccines Poster slam

Speakers

Mr Max Geißler (Institute of Immunology Tübingen)Mr Konrad Merz (Institute of Immunology Tübingen)

Description

Universal influenza vaccine strategies predominantly exploit the conserved hemagglutinin (HA) stalk as a target for broadly neutralizing antibodies. Whether the HA stalk also contributes to protective T cell immunity remains poorly understood. We therefore investigated the underappreciated immunological capacity of HA stalk in shaping CD4+ T cell immunity within our Orf virus–based universal influenza vaccine candidate (ORFV-Flu).
Mice were immunized with ORFV-Flu expressing chimeric HA constructs. Overlapping HA stalk peptide libraries of multiple influenza A virus strains were screened by ELISpot and multiparametric flow cytometry to identify HA stalk–specific CD4⁺ T cell responses.
ORFV-Flu elicited potent HA stalk-specific CD4⁺ T cell responses, establishing the stalk as a dual humoral and cellular immune target through the discovery of immunogenic regions containing candidate MHC class II epitopes.
These findings expand the immunological concept of chimeric HA–based vaccination beyond antibody induction by identifying the HA stalk as a dual-function antigen capable of eliciting both humoral and CD4⁺ T cell immunity. Combined with the potent HA stalk–specific antibody responses and conserved antigen-specific CD8⁺ T cell immunity elicited by ORFV-Flu, these findings complete a coordinated immune framework integrating humoral, helper, and cytotoxic T cell responses for next-generation influenza vaccination.

Registration ID INF26-87
Professional status of the speaker Graduate student
Junior scientist status No, I am not a junior scientist.

Authors

Mr Max Geißler (Institute of Immunology Tübingen) Mr Konrad Merz (Institute of Immunology Tübingen)

Co-authors

Mr Julian Volk (Institute of Immunology Tübingen) Ms Annika Schönsiegel (Institute of Immunology Tübingen) Dr Ralf Amann (Fraunhofer IGB) Prof. Oliver Planz (Institute of Immunology Tübingen)

Presentation materials

There are no materials yet.

External references

Peer reviewing

Paper